Allysine-Targeted Molecular MRI Enables Early Prediction of Chemotherapy Response in Pancreatic Cancer

0
28
Investigators reported the application of an allysine-targeted molecular magnetic resonance imaging probe, MnL3, to provide an early, noninvasive assessment of treatment response in PDAC. Molecular MRI with MnL3 could specifically detect and quantify fibrogenesis in PDAC xenografts.
[Cancer Research]
Abstract